Health Care Services

Pennant

Pennant released FY2026 Q1 earnings on May 6 After-Market EST, actual revenue USD 285.36 M (forecast USD 281.1 M), actual EPS USD 0.24 (forecast USD 0.265)

Pennant to release FY2026 Q1 earnings report on May 6 After-Market EST, forecast revenue USD 281.1 M, EPS USD 0.265

Pennant released FY2025 earnings on February 25 After-Market EST, actual revenue USD 947.71 M (forecast USD 930.08 M), actual EPS USD 0.84 (forecast USD 0.89)

Pennant released FY2025 Q4 earnings on February 25 After-Market EST, actual revenue USD 289.32 M (forecast USD 275.2 M), actual EPS USD 0.24 (forecast USD 0.29)

Pennant to Release FY2025 Q4 Earnings on February 25 After-Market EST, Forecast Revenue USD 275.2 M, EPS USD 0.29

William Blair Analyst Initiates Buy Rating on Pennant Group

Pennant released FY2025 9 Months earnings on November 5 After-Market (EST), actual revenue USD 658.38M, actual EPS USD 0.59

Pennant released FY2025 Q3 earnings on November 5 After-Market EST, actual revenue USD 229.04 M (forecast USD 222.1 M), actual EPS USD 0.17 (forecast USD 0.265)

Pennant to Release FY2025 Q3 Earnings on November 5 After-Market (EST), Forecast Revenue USD 222.1 M, EPS USD 0.265

Wiederhorn Analyzes Healthcare Stocks, Recommends Pennant Group

Analysts Adjust Ratings and Price Targets for Pennant Gr

Wall Street Zen Upgrades Pennant Group Stock Rating to Buy

Pennant released FY2025 Q2 earnings on August 6 After-Market EST, actual revenue USD 219.5 M (forecast USD 210.62 M), actual EPS USD 0.2 (forecast USD 0.245)

Pennant released FY2025 Semi-Annual earnings on August 6 After-Market EST, actual revenue USD 429.34 M, actual EPS USD 0.42

Pennant to release FY2025 Q2 earnings on August 6 After-Market EST, forecast revenue USD 210.62 M, EPS USD 0.245

Pennant Acquires GrandCare to Expand California Presence

Stephens &amp; Co. Reiterates Overweight Rating for Pennant Gr

Wells Fargo Upgrades Pennant Group Target Price

ProShare Advisors LLC Acquires The Pennant Group, Inc. Stock

Pennant Group Director Sells Company Shares

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

PNTG

Pennant Group to Participate in the 2026 RBC Global Healthcare Conference | PNTG Stock News

StockTitan

iShares US Healthcare Providers

VG Health

SPDR S&P Health

ROYAL BANK OF CANADA

Pennant Group to Participate in the 2026 RBC Global Healthcare Conference | PNTG Stock News

The Pennant Group, Inc. (NASDAQ: PNTG) has announced the acquisition of Copper Canyon Memory Care in Tucson, Arizona, expanding its operations by 40 units. CEO Brent Guerisoli emphasized the company's strategic approach to capital deployment and confidence in the Arizona senior housing market. The acquisition aims to enhance operational efficiency and improve resident outcomes, with a focus on community engagement.

Pennant Announces an Acquisition of Senior Living Community in Arizona | PNTG Stock News

Truist Financial has raised its price target for The Pennant Group (NASDAQ:PNTG) from $36.00 to $42.00, maintaining a "buy" rating. This new target suggests a potential upside of 17.68% from the previous close. Other brokerages have also adjusted their ratings, with Royal Bank of Canada setting a target of $42.00 and Zacks Research downgrading to a "hold". The stock traded down 0.1% to $35.69, with a consensus rating of "Moderate Buy" and a target price of $39.00 from analysts.

Market Beat

Truist Financial

Wells Fargo

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

The Pennant Group (NASDAQ:PNTG) Price Target Raised to $42.00 at Truist Financial

Pennant Group Inc (PNTG) reported strong Q1 earnings, with revenue up 36% year-over-year to $285.4 million, driven by acquisitions and organic growth in Home Health & Hospice. Adjusted net income rose 19.8% to $11.5 million. However, integration costs and EMR transition disruptions pose near-term challenges. Home Health & Hospice segment revenue surged 43.3%, while Senior Living revenue increased 12.6%. Despite operational disruptions, management remains optimistic about future growth, emphasizing leadership development and a focus on improving margins.

Tip Ranks

Pennant Group balances rapid growth with integration risk

The Pennant Group (NASDAQ:PNTG) reached a new 52-week high of $35.04 following a strong earnings report, with EPS of $0.32, surpassing estimates of $0.31. The company reported revenue of $285.36 million, exceeding expectations of $280.75 million. Analysts have raised their price targets, with Wells Fargo increasing it to $38.00 and Royal Bank of Canada to $41.00. Institutional investors hold 85.88% of the stock, which has a market cap of $1.21 billion and a P/E ratio of 41.89. The average analyst rating is "Moderate Buy" with a target price of $37.00.

Fifth Third Bancorp

Fifth Third Bancorp Pref Share FITBO 4.95 Perp 09/30/24 K

FIFTH THIRD BANK PREF SHARE FITB V6.625 P12/31/49 I

Fifth Third Bancorp Pref Shares FITBM 6.875 Perp 10/01/30

Fifth Third Bancorp Depositary Shs B Ser A Repr 1/40 6 % Perp Pfd Registered Shs B Ser A

The Pennant Group (NASDAQ:PNTG) Reaches New 52-Week High Following Strong Earnings

Pennant Group reported a strong first-quarter 2026, with revenue rising 36% year-over-year to $285.4 million and GAAP diluted EPS at $0.24. Net income increased 9.6% to $8.5 million, driven by a 43.3% revenue jump in Home Health and Hospice Services. The Senior Living Services segment also performed well, with a 12.6% revenue increase. Analysts rate PNTG stock as a Buy with a $36.00 price target, supported by improving financial performance and a positive earnings outlook, despite some execution risks.

Pennant Group Posts Strong First-Quarter 2026 Revenue Growth

Earnings Watch

Pennant | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 285.36 M

Pennant(PNTG.US)

Pennant Group to Participate in the 2026 RBC Global Healthcare Conference | PNTG Stock News

Pennant Announces an Acquisition of Senior Living Community in Arizona | PNTG Stock News

The Pennant Group (NASDAQ:PNTG) Price Target Raised to $42.00 at Truist Financial

Pennant Group balances rapid growth with integration risk

The Pennant Group (NASDAQ:PNTG) Reaches New 52-Week High Following Strong Earnings

Pennant Group Posts Strong First-Quarter 2026 Revenue Growth

Pennant | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 285.36 M